Recent Updates
Recently added Catalysts
KPTI Positive Sentiment Score: 70/100

Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference

Key Takeaway: Karyopharm Therapeutics Inc. (Nasdaq: KPTI) announced that its senior management will participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference. The session is scheduled for May 15 at 9:30 a.m. ET and will be accessible via a live webcast. This event underscores Karyopharm's ongoing efforts to engage with investors and share insights into its cancer therapies.

Market Sentiment Analysis

POSITIVE FACTORS

  • Karyopharm is participating in a prominent healthcare conference.
  • The event provides an opportunity for investor engagement through a live webcast.
  • Showcases the company's commitment to transparency and communication.

Full Press Release Details

NEWTON, Mass., May 8, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate at the 2024 RBC Capital Markets Global Healthcare Conference in a fireside chat on Wednesday, May 15 at 9:30 a.m. ET.
A live webcast of the fireside chat can be accessed under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations, and will be available for replay following the event.
About Karyopharm Therapeutics
XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc. Any other trademarks referred to in this release are the property of their respective owners.
SOURCE Karyopharm Therapeutics Inc.

21 %

more press release views with

Frequently Asked Questions

When will Karyopharm participate in the RBC Conference?

Karyopharm will join the RBC Capital Markets Global Healthcare Conference on May 15, 2024.

How can I watch the Karyopharm fireside chat?

The fireside chat can be streamed live on Karyopharm's investor website under Events & Presentations.

What are the trademarks of Karyopharm Therapeutics?

XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc.

Where can I find Karyopharm's investor information?

Investor information is available on the Karyopharm Therapeutics website.

Last updated: May 8, 2024